Perspectives - Page 24

Biopharma Innovation in China Showcased at CSCO 2021

Our team participated in the virtual 2021 Chinese Society of Clinical Oncology (CSCO) Annual Meeting in September, and found clear evidence of China’s emergence as a biopharma innovator.

View Oct 28, 2021

Different Perspectives on the Burden of Disease

View Oct 27, 2021

Activating Medical Affairs to Drive Competitive Differentiation Over the Pre-Launch to Early Post-Launch Period

Case Study Oct 24, 2021

Using Technology to Keep Up with the Latest Scientific Information

View Oct 6, 2021

Medical Affairs Unscripted | Launch Readiness: Building, Planning & Execution with Chris Keir, MD, MS

Podcast Sep 28, 2021

A Subscription to Innovation: Could NHS England’s Novel Frameworks for Antimicrobials Be the Future of HTA?

In this piece, Renu and Matthew break down why the market has failed to tackle antimicrobial resistance and look into some of the initiatives created to deal with the problem. Focusing on England’s novel payment evaluation and purchasing frameworks, they investigate how the new ‘de-linked’ approach could impact the development of future treatments.

Whitepaper Sep 24, 2021

Patient-Centered Outcomes Publications

Resource

Go-To-Market (GTM): Market-Shaping Launch Commercialization Planning for a Gene Therapy Asset in a Congenital Rare Disease Therapy Area

Case Study Sep 20, 2021

Women in Biotech Progress – Yet Challenges Remain, Update on Female Innovators in Biotech

View Sep 6, 2021

Heterogeneity & Generalizability: The Core Difficulties in Estimating the Effectiveness of Tumour-Agnostic Drugs in Practice

Whitepaper Sep 3, 2021

Competitor Scenario Planning and Mitigation Strategy Development for Launch Commercialization

Refinement and pressure testing of the launch strategy for a gene replacement therapy asset in a congenital rare disease therapy area, and competitor scenario planning exercise identifying key issues to address through the characterization of competitor launch scenarios

Case Study Aug 26, 2021

Are We Nearing the Plateau of Productivity for In-Vivo Therapeutic Gene Editing?

View Aug 24, 2021

Investment in Therapeutic Innovations for Genetic Disorders – A Brainstorm for the Overall Neurology and Musculoskeletal Sectors

On-Demand Webinar Aug 19, 2021

Women Leaders in Biotechnology Inspire From Kendall Square

View Aug 18, 2021

Novel Cell-Type Therapeutic Platforms in Oncology: If You’ve Seen One, You’ve Seen… One

On-Demand Webinar Aug 11, 2021

Understanding the Payer Mindset Throughout the Brand Journey

Payers have influence at a number of points across a brand's lifecycle. Understanding and managing the impact of this influence is key to unlocking an intervention's commercial potential. We've created a roadmap that outlines the different stages that payers can influence and outlines strategic considerations for brand teams.

Whitepaper Aug 9, 2021